Lista de obras - Monica Rodolfo - Dominio Público Uruguay

A Merging Duo in Melanoma Formation

artículo científico publicado en 2005

A large de novo 9p21.3 deletion in a girl affected by astrocytoma and multiple melanoma

artículo científico publicado en 2014

A variant in FTO shows association with melanoma risk not due to BMI

artículo científico publicado en 2013

AKT1(E17K) in human solid tumours

artículo científico publicado en 2008

Absence of the CD1 molecule up-regulates antitumor activity induced by CpG oligodeoxynucleotides in mice

artículo científico publicado en 2002

Adjuvant adoptive immunotherapy with IL2 and lymphocytes from tumor-bearing mice: in vitro tumor-stimulated lymphocytes are more effective than LAK cells

artículo científico publicado en 1991

Adoptive immunotherapeutic treatments with interleukin 2 and lymphocytes in a mouse colonic adenocarcinoma model

artículo científico publicado en 1990

Alternative activation of human plasmacytoid DCs in vitro and in melanoma lesions: involvement of LAG-3.

artículo científico publicado en 2014

An autologous T cell clone overcomes intra-melanoma heterogeneity for susceptibility to cell-mediated lysis by using multiple lytic mechanisms: in vitro and in vivo analysis

artículo científico publicado en 1991

Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigen.

artículo científico publicado en 2003

Association of microRNA 146a polymorphism rs2910164 and the risk of melanoma in an Italian population

article

Association of promoter polymorphism -765G>C in the PTGS2 gene with malignant melanoma in Italian patients and its correlation to gene expression in dermal fibroblasts.

artículo científico publicado en 2014

BRAF alterations are associated with complex mutational profiles in malignant melanoma

artículo científico publicado en 2004

CDKN2A and MC1R variants influence dermoscopic and confocal features of benign melanocytic lesions in multiple melanoma patients.

artículo científico publicado en 2013

CTAB-urea method purifies RNA from melanin for cDNA microarray analysis

artículo científico publicado en 2004

Clinical genetic testing for familial melanoma in Italy: A cooperative study

article

Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma

scientific article published in 2018

Common Delayed Senescence of Melanocytes from Multiple Primary Melanoma Patients

artículo científico publicado en 2016

Cooperative effects of Mycobacterium tuberculosis Ag38 gene transduction and interleukin 12 in vaccination against spontaneous tumor development in proto-neu transgenic mice

artículo científico publicado en 2000

Cutaneous Melanoma in Childhood and Adolescence Shows Frequent Loss of INK4A and Gain of KIT

article

Cytotoxic T lymphocyte response against non-immunoselected tumor antigens predicts the outcome of gene therapy with IL-12-transduced tumor cell vaccine.

artículo científico publicado en 1999

Cytotoxic T lymphocytes recognize tumor antigens of a murine colonic carcinoma by using different T-cell receptors

artículo científico publicado en 1994

DHCR24 gene expression is upregulated in melanoma metastases and associated to resistance to oxidative stress-induced apoptosis

artículo científico publicado en 2005

Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte respons

artículo científico publicado en 1999

Detection of mutated BRAFV600E variant in circulating DNA of stage III–IV melanoma patients

artículo científico publicado en 2007

Genetic progression of metastatic melanoma.

artículo científico publicado en 2004

Genetic unresponsiveness to a murine fibrosarcoma determined by the host genetic environment but not by lymphocyte precursor genotype

Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility

artículo científico publicado en 2020

Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo

artículo científico publicado en 1991

Growth inhibition of murine colonic adenocarcinoma by tumor immune but not by IL-2-activated or alloactivated lymphocytes

scientific article published on 01 February 1987

Growth of human melanoma xenografts is suppressed by systemic angiostatin gene therapy.

artículo científico publicado en 2001

H-2K restriction of the T cell-mediated lysis of a chemically-induced BALB/c fibrosarcoma

artículo científico publicado en 1983

Heterogeneity and phenotypic instability of chemotherapeutic and immunologic sensitivity in murine and human melanoma cell clones.

artículo científico publicado en 1992

High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells

artículo científico publicado en 2007

Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals

artículo científico publicado en 2014

Honokiol bis-dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma in vivo

artículo científico publicado en 2016

IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors

artículo científico publicado en 2009

IL-4-transduced tumor cell vaccine induces immunoregulatory type 2 CD8 T lymphocytes that cure lung metastases upon adoptive transfer.

artículo científico publicado en 1999

Identification of MET and SRC activation in melanoma cell lines showing primary resistance to PLX4032.

artículo científico publicado en 2011

IgG2a induced by interleukin (IL) 12-producing tumor cell vaccines but not IgG1 induced by IL-4 vaccine is associated with the eradication of experimental metastases

artículo científico publicado en 1998

Immune cells in the melanoma microenvironment hold information for prediction of the risk of recurrence and response to treatment

artículo científico publicado en 2014

Immune response markers in sentinel nodes may predict melanoma progression

artículo científico publicado en 2014

Immunizing potential of cytokine-transduced tumor cells

artículo científico publicado en 2000

Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy

scientific article published on 29 October 2018

Immunotherapy of experimental metastases by vaccination with interleukin gene-transduced adenocarcinoma cells sharing tumor-associated antigens. Comparison between IL-12 and IL-2 gene-transduced tumor cell vaccines.

artículo científico publicado en 1996

Integrated transcriptional-phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patients

artículo científico publicado en 2021

Interleukin 12 potentiates the curative effect of a vaccine based on interleukin 2-transduced tumor cells

artículo científico publicado en 1996

MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents

artículo científico publicado en 2006

Malignant and benign tumors associated with multiple primary melanomas: just the starting block for the involvement of MITF, PTEN and CDKN2A in multiple cancerogenesis?

artículo científico publicado en 2013

MelaNostrum: a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortium

artículo científico publicado en 2018

Melanoma risk alleles are associated with downregulation of the MTAP gene and hypermethylation of a CpG island upstream of the gene in dermal fibroblasts

article

MicroRNA expression profiles associated with mutational status and survival in malignant melanoma

artículo científico publicado en 2010

Modulation of the myeloid compartment of the immune system by angiogenic- and kinase inhibitor-targeted anti-cancer therapies.

artículo científico publicado en 2014

Molecular profiling of the "plexinome" in melanoma and pancreatic cancer

artículo científico publicado en 2009

Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup.

artículo científico publicado en 2016

Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

artículo científico publicado en 1996

Mutational profile of GNAQQ209 in human tumors.

artículo científico publicado en 2009

Mutational profiling of cancer candidate genes in glioblastoma, melanoma and pancreatic carcinoma reveals a snapshot of their genomic landscapes

artículo científico publicado en 2009

New common variants affecting susceptibility to basal cell carcinoma

artículo científico publicado en 2009

Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma

artículo científico publicado en 2007

Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b

artículo científico publicado en 2015

Postsurgical adjuvant chemoimmunotherapy with recombinant interleukin-2 and 1,3-bis-(2-chloroethyl)-1-nitrosurea on spontaneous metastases of a non-immunogenic murine tumour

artículo científico publicado en 1992

Prevention of spontaneous mammary adenocarcinoma in HER-2/neu transgenic mice by foreign DNA

scientific article published on 01 November 2002

Promoter methylation of aminopeptidase N/CD13 in malignant melanoma.

artículo científico publicado en 2012

Prosurvival effect of DHCR24/Seladin-1 in acute and chronic responses to oxidative stress

artículo científico publicado en 2007

RNASET2 as a tumor antagonizing gene in a melanoma cancer model.

artículo científico publicado en 2008

Regulatory role of CCN3 in melanoma cell interaction with the extracellular matrix

artículo científico publicado en 2009

Role of T cells and tumour necrosis factor in antitumour activity and toxicity of flavone acetic acid

artículo científico publicado en 1990

Selective purging by human interleukin-2 activated lymphocytes of bone marrows contaminated with a lymphoma line or autologous leukaemic cells

artículo científico publicado en 1991

Sex-specific effect of RNASEL rs486907 and miR-146a rs2910164 polymorphisms' interaction as a susceptibility factor for melanoma skin cancer.

artículo científico publicado en 2017

Targeting Immune Regulatory Networks to Counteract Immune Suppression in Cancer

artículo científico publicado en 2016

Targeting p63 upregulation abrogates resistance to MAPK inhibitors in melanoma

scientific article published on 14 April 2020

Therapeutic use of a long-term cytotoxic T cell line recognizing a common tumour-associated antigen: the pattern of in vitro reactivity predicts the in vivo effect on different tumours

artículo científico publicado en 1991

Transcriptional profiling of melanoma sentinel nodes identify patients with poor outcome and reveal an association of CD30(+) T lymphocytes with progression

artículo científico

Treatment of a low immunogenic experimental tumour with alloactivated or tumour-immune lymphocytes

artículo científico publicado en 1987

Tumor cells engineered to produce cytokines or cofactors as cellular vaccines: do animal studies really support clinical trials?

artículo científico publicado en 1995

Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma

artículo científico publicado en 2018

microRNA Expression in Sentinel Nodes from Progressing Melanoma Patients Identifies Networks Associated with Dysfunctional Immune Response

artículo científico

pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity

artículo científico publicado en 2010

Lista de obras de Monica Rodolfo

A Merging Duo in Melanoma Formation

A large de novo 9p21.3 deletion in a girl affected by astrocytoma and multiple melanoma

A variant in FTO shows association with melanoma risk not due to BMI

AKT1(E17K) in human solid tumours

Absence of the CD1 molecule up-regulates antitumor activity induced by CpG oligodeoxynucleotides in mice

Adjuvant adoptive immunotherapy with IL2 and lymphocytes from tumor-bearing mice: in vitro tumor-stimulated lymphocytes are more effective than LAK cells

Adoptive immunotherapeutic treatments with interleukin 2 and lymphocytes in a mouse colonic adenocarcinoma model

Alternative activation of human plasmacytoid DCs in vitro and in melanoma lesions: involvement of LAG-3.

An autologous T cell clone overcomes intra-melanoma heterogeneity for susceptibility to cell-mediated lysis by using multiple lytic mechanisms: in vitro and in vivo analysis

Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigen.

Association of microRNA 146a polymorphism rs2910164 and the risk of melanoma in an Italian population

Association of promoter polymorphism -765G>C in the PTGS2 gene with malignant melanoma in Italian patients and its correlation to gene expression in dermal fibroblasts.

BRAF alterations are associated with complex mutational profiles in malignant melanoma

CDKN2A and MC1R variants influence dermoscopic and confocal features of benign melanocytic lesions in multiple melanoma patients.

CTAB-urea method purifies RNA from melanin for cDNA microarray analysis

Clinical genetic testing for familial melanoma in Italy: A cooperative study

Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma

Common Delayed Senescence of Melanocytes from Multiple Primary Melanoma Patients

Cooperative effects of Mycobacterium tuberculosis Ag38 gene transduction and interleukin 12 in vaccination against spontaneous tumor development in proto-neu transgenic mice

Cutaneous Melanoma in Childhood and Adolescence Shows Frequent Loss of INK4A and Gain of KIT

Cytotoxic T lymphocyte response against non-immunoselected tumor antigens predicts the outcome of gene therapy with IL-12-transduced tumor cell vaccine.

Cytotoxic T lymphocytes recognize tumor antigens of a murine colonic carcinoma by using different T-cell receptors

DHCR24 gene expression is upregulated in melanoma metastases and associated to resistance to oxidative stress-induced apoptosis

Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte respons

Detection of mutated BRAFV600E variant in circulating DNA of stage III–IV melanoma patients

Genetic progression of metastatic melanoma.

Genetic unresponsiveness to a murine fibrosarcoma determined by the host genetic environment but not by lymphocyte precursor genotype

Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility

Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo

Growth inhibition of murine colonic adenocarcinoma by tumor immune but not by IL-2-activated or alloactivated lymphocytes

Growth of human melanoma xenografts is suppressed by systemic angiostatin gene therapy.

H-2K restriction of the T cell-mediated lysis of a chemically-induced BALB/c fibrosarcoma

Heterogeneity and phenotypic instability of chemotherapeutic and immunologic sensitivity in murine and human melanoma cell clones.

High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells

Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals

Honokiol bis-dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma in vivo

IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors

IL-4-transduced tumor cell vaccine induces immunoregulatory type 2 CD8 T lymphocytes that cure lung metastases upon adoptive transfer.

Identification of MET and SRC activation in melanoma cell lines showing primary resistance to PLX4032.

IgG2a induced by interleukin (IL) 12-producing tumor cell vaccines but not IgG1 induced by IL-4 vaccine is associated with the eradication of experimental metastases

Immune cells in the melanoma microenvironment hold information for prediction of the risk of recurrence and response to treatment

Immune response markers in sentinel nodes may predict melanoma progression

Immunizing potential of cytokine-transduced tumor cells

Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy

Immunotherapy of experimental metastases by vaccination with interleukin gene-transduced adenocarcinoma cells sharing tumor-associated antigens. Comparison between IL-12 and IL-2 gene-transduced tumor cell vaccines.

Integrated transcriptional-phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patients

Interleukin 12 potentiates the curative effect of a vaccine based on interleukin 2-transduced tumor cells

MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents

Malignant and benign tumors associated with multiple primary melanomas: just the starting block for the involvement of MITF, PTEN and CDKN2A in multiple cancerogenesis?

MelaNostrum: a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortium

Melanoma risk alleles are associated with downregulation of the MTAP gene and hypermethylation of a CpG island upstream of the gene in dermal fibroblasts

MicroRNA expression profiles associated with mutational status and survival in malignant melanoma

Modulation of the myeloid compartment of the immune system by angiogenic- and kinase inhibitor-targeted anti-cancer therapies.

Molecular profiling of the "plexinome" in melanoma and pancreatic cancer

Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup.

Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

Mutational profile of GNAQQ209 in human tumors.

Mutational profiling of cancer candidate genes in glioblastoma, melanoma and pancreatic carcinoma reveals a snapshot of their genomic landscapes

New common variants affecting susceptibility to basal cell carcinoma

Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma

Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b

Postsurgical adjuvant chemoimmunotherapy with recombinant interleukin-2 and 1,3-bis-(2-chloroethyl)-1-nitrosurea on spontaneous metastases of a non-immunogenic murine tumour

Prevention of spontaneous mammary adenocarcinoma in HER-2/neu transgenic mice by foreign DNA

Promoter methylation of aminopeptidase N/CD13 in malignant melanoma.

Prosurvival effect of DHCR24/Seladin-1 in acute and chronic responses to oxidative stress

RNASET2 as a tumor antagonizing gene in a melanoma cancer model.

Regulatory role of CCN3 in melanoma cell interaction with the extracellular matrix

Role of T cells and tumour necrosis factor in antitumour activity and toxicity of flavone acetic acid

Selective purging by human interleukin-2 activated lymphocytes of bone marrows contaminated with a lymphoma line or autologous leukaemic cells

Sex-specific effect of RNASEL rs486907 and miR-146a rs2910164 polymorphisms' interaction as a susceptibility factor for melanoma skin cancer.

Targeting Immune Regulatory Networks to Counteract Immune Suppression in Cancer

Targeting p63 upregulation abrogates resistance to MAPK inhibitors in melanoma

Therapeutic use of a long-term cytotoxic T cell line recognizing a common tumour-associated antigen: the pattern of in vitro reactivity predicts the in vivo effect on different tumours

Transcriptional profiling of melanoma sentinel nodes identify patients with poor outcome and reveal an association of CD30(+) T lymphocytes with progression

Treatment of a low immunogenic experimental tumour with alloactivated or tumour-immune lymphocytes

Tumor cells engineered to produce cytokines or cofactors as cellular vaccines: do animal studies really support clinical trials?

Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma

microRNA Expression in Sentinel Nodes from Progressing Melanoma Patients Identifies Networks Associated with Dysfunctional Immune Response

pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity